Lilly (LLY.US) establishes global weight loss drug strategy: replicating the successful US model, but taking a cautious approach to rapid approval of new drugs.

Zhtng cijng APP hu x, l li (LLY.US) guj yw zng ci Patrik Jonsson zhusn biosh, gi gngs y chngwi uzhu, yzhu h zhngdng dq jinfi yow shchng de lngdozh, bng yuwng zi qunqi fzh q zi Migu shchng de zhdo dwi. T hi biosh, l li du lyng Migu shpn yo chn jin gunl jnwi (FDA) de xn kuis shnp chngx li shnch q shyngxng kuf jinfi yow Orforglipron chngun tidu.